UNSPSC 50501514: Choline

This classification denotes a water-soluble vitamin with the molecular formula C5H14NO, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier N91BDP6H0X, chemically known as 2-hydroxy-n,n,n-trimethylethanaminium but more generally known as choline, which bears U.S. National Institutes of Health Compound Identifier 305. The European Medicines Agency schedules Choline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13349MIG.

CHOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: OCC[N](C)(C)C

UNSPSC 50501514 Choline (Commodity) does not align with the state and local procurement activity currently tagged under this code. The recent opportunities solicited under this UNSPSC designation involve naloxone and drug deactivation systems, direct-to-manufacturer pharmacy prescriptions, and generic multi-source pharmaceuticals and over-the-counter products—none of which are choline or choline-related products. The code appears to show little relevant recent activity for its nominal scope; the mismatch suggests either a cataloging error in the source data or a fundamental misalignment between the code assignment and the actual goods being procured.

The three opportunities on record span different issuing bodies and procurement mechanisms: Seminole County, Florida (IFB for naloxone and drug deactivation systems, due July 26, 2023); the Texas Health and Human Services Commission (RFI for direct-to-manufacturer prescription programs, posted April 3, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance administered by the Minnesota Department of Administration (RFP for generic pharmaceuticals and OTC products, due March 26, 2026). Without current opportunities that actually match the choline commodity description, the code does not present a clear purchasing signal for business development purposes.